Your browser doesn't support javascript.
loading
Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial.
Lu, Shun; Wang, Qiming; Zhang, Guojun; Dong, Xiaorong; Yang, Cheng-Ta; Song, Yong; Chang, Gee-Chen; Lu, You; Pan, Hongming; Chiu, Chao-Hua; Wang, Zhehai; Feng, Jifeng; Zhou, Jianying; Xu, Xingxiang; Guo, Renhua; Chen, Jianhua; Yang, Haihua; Chen, Yuan; Yu, Zhuang; Shiah, Her-Shyong; Wang, Chin-Chou; Yang, Nong; Fang, Jian; Wang, Ping; Wang, Kai; Hu, Yanping; He, Jianxing; Wang, Ziping; Shi, Jianhua; Chen, Shaoshui; Wu, Qiong; Sun, Changan; Li, Chuan; Wei, Hongying; Cheng, Ying; Su, Wu-Chou; Hsia, Te-Chun; Cui, Jiuwei; Sun, Yuping; Ou, Sai-Hong Ignatius; Zhu, Viola W; Chih-Hsin Yang, James.
Afiliación
  • Lu S; Department of Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China. Electronic address: shunlu@sjtu.edu.cn.
  • Wang Q; Department of Internal Medicine, Henan Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou, People's Republic of China.
  • Zhang G; Department of Respiration, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
  • Dong X; Cancer Center, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Yang CT; Department of Thoracic Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Song Y; Department of Respiration, General Hospital of The PLA Eastern Theater Command, Nanjing, People's Republic of China.
  • Chang GC; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Lu Y; Department of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, People's Republic of China.
  • Pan H; Department of Oncology, Sir Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  • Chiu CH; Division of Thoracic Oncology, Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Wang Z; Department of Oncology, Shandong Cancer Hospital, Jinan, People's Republic of China.
  • Feng J; Department of Internal Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
  • Zhou J; Department of Respiratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Xu X; Department of Respiration, Northern Jiangsu People's Hospital, The Affiliated Hospital to Yangzhou University, Yangzhou, People's Republic of China.
  • Guo R; Department of Medical Oncology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
  • Chen J; Department of Medical Oncology-Chest, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Yang H; Department of Radiotherapy, Taizhou Hospital of Zhejiang Province, Taizhou, People's Republic of China.
  • Chen Y; Department of Oncology, Tongji Medical College Huazhong University of Science & Technology, Wuhan, People's Republic of China.
  • Yu Z; Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
  • Shiah HS; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Wang CC; Department of Occupational Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
  • Yang N; Department of Pulmonary Gastroenterology, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Fang J; Department of Chest Medicine, Beijing Cancer Hospital, Beijing, People's Republic of China.
  • Wang P; Department of Radiotherapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin, People's Republic of China.
  • Wang K; Department of Respiration, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Hu Y; Department of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, People's Republic of China.
  • He J; Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
  • Wang Z; Department of Chest Medicine, Beijing Cancer Hospital, Beijing, People's Republic of China.
  • Shi J; Department of Internal Medicine, Linyi Cancer Hospital, Linyi, People's Republic of China.
  • Chen S; Department of Oncology, Binzhou Medical University Hospital, Binzhou, People's Republic of China.
  • Wu Q; Clinical Medical Group, Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Shanghai, People's Republic of China.
  • Sun C; Clinical Operation Group, Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Shanghai, People's Republic of China.
  • Li C; Clinical Medical Group, Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Shanghai, People's Republic of China.
  • Wei H; Clinical Medical Group, Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Shanghai, People's Republic of China.
  • Cheng Y; Department of Internal Medicine, Jilin Cancer Hospital, Changchun, People's Republic of China.
  • Su WC; Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Taipei, Taiwan.
  • Hsia TC; Division of Pulmonary and Critical Care Medicine, China Medical University Hospital, Taichung, Taiwan.
  • Cui J; Department of Oncology, The First Bethune Hospital of Jilin University, Changchun, People's Republic of China.
  • Sun Y; Department of Oncology, Jinan Central Hospital, Jinan, People's Republic of China.
  • Ou SI; Chao Family Comprehensive Cancer Center, Department of Medicine, Division of Hematology and Oncology, University of California, Irvine School of Medicine, Orange, California.
  • Zhu VW; Chao Family Comprehensive Cancer Center, Department of Medicine, Division of Hematology and Oncology, University of California, Irvine School of Medicine, Orange, California.
  • Chih-Hsin Yang J; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
J Thorac Oncol ; 17(3): 411-422, 2022 03.
Article en En | MEDLINE | ID: mdl-34801749
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article